Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-21-135795
Filing Date
2021-11-09
Accepted
2021-11-08 18:18:53
Documents
5
Effectiveness Date
2021-11-09

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2132154d1_s8.htm S-8 59598
2 EXHIBIT 5.1 tm2132154d1_ex5-1.htm EX-5.1 10843
3 EXHIBIT 23.2 tm2132154d1_ex23-2.htm EX-23.2 2252
4 EXHIBIT 23.3 tm2132154d1_ex23-3.htm EX-23.3 2330
5 GRAPHIC tm2132154d1_ex5-1img001.jpg GRAPHIC 2097
  Complete submission text file 0001104659-21-135795.txt   79037
Mailing Address 535 BOYLSTON STREET BOSTON MA 02116
Business Address 535 BOYLSTON STREET BOSTON MA 02116 6095104718
Aprea Therapeutics, Inc. (Filer) CIK: 0001781983 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-260884 | Film No.: 211389254
SIC: 2834 Pharmaceutical Preparations